Promethium Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Promethium Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.57M	Hold	41,150	–	–	1.26%	23
2026 Q2	$2.37M	Sell	41,150 -3,500	-8%	-$201K	1.14%	27
2026 Q1	$2.71M	Buy	44,650 +600	+1%	+$35K	1.4%	23
2025 Q4	$2.38M	Hold	44,050	–	–	1.28%	24
2025 Q3	$1.99M	Hold	44,050	–	–	1.14%	33
2025 Q2	$2.04M	Sell	44,050 -2,000	-4%	-$98.2K	1.24%	30
2025 Q1	$2.81M	Sell	46,050 -10,000	-18%	-$583K	1.8%	17
2024 Q4	$3.17M	Sell	56,050 -13,500	-19%	-$754K	2.17%	8
2024 Q3	$3.6M	Buy	+69,550	New	+$3.26M	2.54%	4

Other funds holding BMY

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Promethium Advisors's BMY Position: Q3 2026 in Review

Promethium Advisors held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 41,150 shares worth $2.57M. The position accounts for 1.26% of the portfolio, ranked #23.

Promethium Advisors first reported a position in BMY in Q3 2024 and has held it in 9 quarters since. The position peaked at $3.6M in Q3 2024. 1,093 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Promethium Advisors held 41,150 shares of Bristol-Myers Squibb worth $2.57M as of Q3 2026.
Promethium Advisors left its Bristol-Myers Squibb share count unchanged in Q3 2026.
Bristol-Myers Squibb made up 1.26% of Promethium Advisors's portfolio in Q3 2026, its #23 holding.
Promethium Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 9 quarters since.
Promethium Advisors's Bristol-Myers Squibb position peaked at $3.6M in Q3 2024.
1,093 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Promethium Advisors's 13F filing for Q3 2026, filed 19 Oct 2026.